Biotech Values

[Kadaicher1]

Prana presentation. Alzheimers. It is worth going onto the R&R site at least to look at the slides. It is archived at http://wsw.com/webcast/rrshq12/pran/
This drug is regarded, and priced, as a long shot, but looking at that presentation, I gather PRAN are expecting impressive results from their phase2 ending next month. Their old PBT1 drug
has already shown impressiv efficacy, but the PBT2 is said to be purer, safer and fifty times as effective. That is right, 50 times more of he drug gets to the brain. On another slide they say the next phase2 could be a pivitol trial for EU approval.